This video analyzes a pathological case identified as a superficial angiomyxoma (also referred to as cutaneous myxoma). The lesion is characterized as a blue, hypocellular, lobulated nodule set in a myxoid background, featuring abundant, branching, and thick-walled vascular spaces. The presentation distinguishes superficial angiomyxoma from its deeper intramuscular counterpart, emphasizing the greater vascularity in the superficial variant. The speaker provides an extensive differential diagnosis, discussing how to differentiate it from key lookalikes, including myxoid liposarcoma (which has more delicate vessels and a deeper location), low-grade myxofibrosarcoma (which requires atypical/pleomorphic cells), and focal cutaneous mucinosis (which lacks the multinodularity and prominent vessels). Additionally, the presentation covers associated features such as the presence of scattered neutrophils and the potential overlap with adnexal tumors when entrapment of adnexal structures occurs. Finally, guidance is offered on assessing risk for Carney syndrome and differentiating this lesion from the deep, aggressive angiomyxoma based on size and anatomical location.
Pathological Analysis of Superficial Angiomyxoma (Cutaneous Myxoma)
0:07 Initial Assessment: Case 25 is described as a blue, pale, hypocellular, lobulated nodule with small vascular spaces, leading to the differential diagnosis of angiomixoma.
0:38 Defining Superficial Angiomyxoma: The lesion is confirmed as superficial angiomyxoma (AKA cutaneous myxoma). The speaker emphasizes this differs significantly from deep intramuscular myxoma.
Key Feature: Superficial angiomyxoma is characterized by more abundant, branching vascularityβa feature that makes the term "angiomixoma" apt. The lesion contains bland spindle cells and a multilobular hypocellular myxoid background.
1:38 Differential Diagnosis (Myxoid Liposarcoma): Branching vessels in a myxoid matrix could raise concern for myxoid liposarcoma (MLS).
Distinction: MLS is typically deep (below the fascia) and extremely rare in the skin. The vessels in superficial angiomyxoma are much thicker walled compared to the very delicate, capillary-sized vessels characteristic of MLS.
2:44 Key Diagnostic Clue (Neutrophils): The presence of scattered neutrophils floating in the myxoid background is a unique and great clue for cutaneous myxoma/superficial angiomyxoma (assuming no overlying ulceration).
4:15 Adnexal Entrapment: About 25% of cutaneous myxomas can exhibit the entrapment and cystic change of adnexal structures (sweat ducts or hair follicles).
Caveat: This overlap causes debate as to whether these cases represent a soft tissue tumor (angiomyxoma) or an adnexal tumor (like trichodiscoma) with abundant myxoid stroma. (Clinically, both are benign.)
6:36 Differential Diagnosis (Focal Cutaneous Mucinosis): Superficial angiomyxoma is distinguished from focal cutaneous mucinosis (FCM) by its multinodular structure, prominent vessels, and larger, deeper extension. FCM is typically a small, incidental intradermal finding.
7:30 Differential Diagnosis (Myxofibrosarcoma - MFS): Low-grade MFS can appear hypocellular and bland.
Critical Distinction: To diagnose even Grade 1 MFS, one must observe ugly hyperchromatic spindle cells (pleomorphism). If atypia is absent, MFS should not be diagnosed. Worry particularly if the lesion is large, deep, and on the extremity of an elderly adult.
9:00 Carney Syndrome Association: Cutaneous myxomas are seen in Carney syndrome, especially if they are multiple or located in specific sites (ear, near the eye, or on the nipple). A solitary lesion does not always mandate screening.
9:30 Differential Diagnosis (Aggressive Angiomyxoma): This deep entity (usually in the vulva/genitals) is primarily differentiated by size and location.
Distinction: Superficial angiomyxoma is small (a couple of centimeters) and located in the dermis/subcutis. Aggressive angiomyxoma is a large, deep soft tissue mass growing into the pelvic area. Histologically, the aggressive variant is often more edematous than classically myxoid.